Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE.

Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE. Mult Scler. 2015 Jul; 21(8):1025-35.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.